Warning: This security is no longer trading.
defunct
Therapix Biosciences Ltd. (TRPX): Price and Financial Metrics
TRPX Price/Volume Stats
| Current price | $0.32 | 52-week high | $4.69 |
| Prev. close | $0.62 | 52-week low | $0.25 |
| Day low | $0.30 | Volume | 7,099,200 |
| Day high | $0.40 | Avg. volume | 1,587,268 |
| 50-day MA | $0.53 | Dividend yield | N/A |
| 200-day MA | $1.06 | Market Cap | 1.12M |
TRPX Stock Price Chart Interactive Chart >
Therapix Biosciences Ltd. (TRPX) Company Bio
Therapix Biosciences Ltd., a specialty pharmaceutical company, develops drugs based on cannabinoid molecules. Its drug development programs include Joint Pharma that develops THX-TS01 for the treatment of Tourette Syndrome (TS); and BrainBright Pharma, which develops THX-ULD01 targeted to the ultra-low dose formulation of dronabinol, combined with sublingual and nasal delivery methods, to provide treatment for Mild Cognitive Impairment (MCI). The company was formerly known as NasVax Ltd. and changed its name to Therapix Biosciences Ltd. in November 2013. Therapix Biosciences Ltd. was founded in 2004 and is based in Tel Aviv, Israel.
TRPX Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | -79.62% |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | 0.00% |
| 2019 | -65.66% |
Loading social stream, please wait...